# Advanced Oncotherapy Confidence greatly boosted

- Link: https://www.directorstalkinterviews.com/advanced-oncotherapy-confidence-greatly-boosted/412747433
- Published: 2018-03-15T13:17:07+00:00
- Author: Giles Arbor

**[⌊Hardman & Co Report Report Downloads⌉⌊Hardman & Co Report Report Downloads⌉[Advanced Oncotherapy
Plc** (LON:AVO) is focused on delivering a more affordable, novel, proton-based 
radiotherapy system, based on technology developed originally at the world-renowned
CERN. Major technical milestones were achieved in 2017 and the company remains on
track with its development plan. Confidence has been enhanced significantly with
integration of the first three structures and overcoming the technical challenge
of accelerating the proton beam. Meanwhile, construction of the Harley Street site
is on schedule for completion in 1H 2018, and new financing and distribution arrangements
add further to confidence about the whole project.

**Strategy:** To develop a compact and modular proton therapy (PT) system at an 
affordable price for the payor, financially attractive to the operator, and generating
superior patient outcomes. AVO benefits from the technology know-how developed by
ADAM, Geneva, and relies on a base of world-class suppliers.

**Technical milestones:** Two major milestones were delivered on time in 2017 and,
with most of the modular components to complete the machine already on site in Geneva,
further integration work is underway to accelerate the proton beam to its target
energy level. The LIGHT project is being increasingly de-risked.

**Commercialisation:** Strong manufacturing partners, and Thales’ infrastructure
and experience will allow mass production of a proton accelerator for the first 
time, in a multi-billion-dollar market. With construction progress at its Harley
Street site, AVO is confident of having a LIGHT system fully tested in 2019.

**Risks:** The funding risk has now reduced greatly, although release of cash from
the People’s Republic of China requires approval from the Government. The more complex
technical challenges of the LIGHT project have been overcome, and integration of
the different units follows known working prototypes.

**Investment summary:** Demand for PT is increasing worldwide and the need for a
small, flexible, affordable and close-to-patient machine is desirable. Advanced 
Oncotherapy Plc has attracted strong partners and discussions with potential customers
have started already. Attention is focused on the construction timetable for the
flagship Harley Street site and installation of the first LIGHT system. Resolution
of AVO’s financing requirements brings further assurance.

Share on:
